一个新的铜(Ⅱ)配合物的合成、结构与抗微生物活性研究

利用苯妥英,二(3-氨基丙基)胺与醋酸铜反应合成了一种新的铜三元配合物[Cu(pht)2(bapa)](CH3OH)[Hpht:苯妥英(5,5-Diphenylhydantion);bapa:二(3-氨基丙基)胺(bis(3-aminopropyl)amine)].通过元素分析、红外光谱和X射线单晶衍射确定了其组成和结构.配合物属于三斜晶系,空间群为Pī.晶胞参数:a=0.84190(10)nm,b=1.37540(15)nm,c=1.5622(2)nm,α=86.038(3)°,β=82.542(2)°,γ=83.904(2)°;V=1.7807(4)nm3,Mr=729.32,Z=2,F(000)=766,Dc=1.360 g/cm3,μ=0.666 mm-1,R1=0.0692,wR2=0.1430.配合物中铜离子配位数为5,处于变形三角双锥配位环境中.测试了配合物、配体和铜盐的抑菌活性,结果表明,它们对4种细菌均有一定的活性.     

配合物[Cu(abpa)(pht)] pht·CH3OH的合成、晶体结构和抗微生物活性

利用加热法合成了标题配合物[Cu(abpa)(pht)] pht·CH3OH(Hpht:苯妥英,即5,5-二苯基-2,2咪唑烷酮; abpa:(2-氨基乙基)-二(氨基丙基)胺),采用元素分析、红外光谱、热重分析、X-射线单晶衍射等技术对其结构进行了表征.该晶体属三斜晶系,Pī空间群,晶胞参数:a= 0.8497(2) nm,b= 1.4120(3) nm,c=1.7150(3) nm,α= 67.544(2) °,β= 87.434(3) °,γ=76.842(3) °;V=1.8496(6) nm3,Dc=1.387 mg/m3,Z=2,F(000)=814,μ=0.646 mm-1,R1= 0.0980,wR2 = 0.2180 [I>2σ(I)].每个配合物分子由一个(2-氨基乙基)-二(氨基丙基)胺苯妥英合Cu(II)阳离子、一个苯妥英阴离子及一个溶剂化甲醇分子构成;配合物中每个Cu(II) 离子与来自一个苯妥英的1个N 原子和一个(2-氨基乙基)-二(氨基丙基)胺的4个N原子配位, 形成畸变的三角双锥结构单元.利用琼脂扩散法和单片滤纸法测试了配合物、配体和铜盐的抑菌活性,结果表明,它们对4种植物致病真菌和3种细菌均有一定的抑菌活性.     

之字链配合物Cu(phth)2(H2O)2的合成、表征及晶体结构

用Cu(NO3)2·3H2O和phth(邻苯二甲酸)混合反应得到了配合物Cu(phth)2(H2O)2(1).通过元素分析、红外光谱对配合物进行了表征,用X射线单晶衍射仪测定了配合物的晶体结构.配合物为单斜晶系,P2(1)/c空间群.晶胞参数a=0.83895(17)nm,b=1.4441(3)nm,c=0.70992(14)nm,β=112.14(3)°,V=0.7967(3)nm3,Z=2,Dc=1.792 g/cm3,F(000)=438.0,S=1.100,R1=0.0376,wR2=0.0998.铜原子为四配位,呈畸变正方形构型,通过邻苯二甲酸根的π-π堆积作用形成了一维之字型链,相邻的链之间靠氢键和π-π堆积作用形成三维分子结构.     

钴(Ⅱ)三元配合物[Co(pht)2(MeOH)2(H2O)2]的合成与晶体结构

利用溶剂热法合成了一个新的钴(Ⅱ)配合物[Co(pht)2(MeOH)2(H2O)2](Hpht:苯妥英,即5,5-二苯基-2,2咪唑烷酮),通过元素分析、红外光谱、热重差热分析、X射线单晶衍射等技术对其结构进行了表征.单晶结构分析表明,该晶体属单斜晶系,P21/C空间群,晶胞参数:a=1.2124(2)nm,b=1.09996(19)nm,c=1.1574(2)nm,β=92.555(2)°,V=1.5419(5)nm3,Dc=1.425 mg/m3,Z=2,F(000)=690,μ=0.615 nm-1,R1=0.0467,wR2=0.1116[I>2σ(I)],GOF=1.026.Co(Ⅱ)离子位于八面体的中心,与六个配位原子配位(40+2N).     

一氯桥双核铜配合物:Cu2(phen)2Cl4的合成、晶体结构及性质研究

本文报导了Cu2(phen)2Cl4配合物的合成方法.X射线衍射分析表明标题配合物属单斜晶系,空间群Cc(no.9),晶胞参数:a=0.9864(2)nm,b=1.7860(4)nm,c=1.3398(3)nm,β=106.60(3)°,V=2.262(8)nm3,Dc=1.848g/cm3,F(000)=1256,Z=4.3064个独立衍射点中2812个满足F2o2σ(F2o),R1和wR2分别为0.0482和0.1066.标题配合物由双核[Cu2(phen)2Cl4]络分子组成,每个铜原子与邻菲NFED4啉配体的2个N原子和3个Cl原子配位形成畸变CuN2Cl3四方锥.配位多面体通过两氯原子形成共棱的Cu2N4Cl6双四方锥.通过氢键和芳环堆积作用,络分子形成三维网络结构.标题配合物为顺磁物质,在5～300K区间内遵循Curie-Weiss定律,χm(T+0.649)=0.405cm3*K*mol-1(χm为每摩尔Cu2+离子磁化率),其Cu2+离子的室温有效磁矩为1.8 B.M.,与Cu2+自由离子的磁矩基本相同,表明铜离子之间不存在磁交换作用.热分析显示该配合物在290℃以下非常稳定.     

双核铜配合物[Cu(pht)_2(ba)_2]_2的合成、晶体结构和抑菌活性

由过渡金属Cu(Ⅱ)、苯妥英(Hpht)与苄胺(ba)反应,得到一种新型双核铜配合物[Cu(pht)_2(ba)_2]_2,通过元素分析、摩尔电导、红外光谱、X-射线单晶衍射等对配合物的结构进行了解析和表征.结果表明:该晶体属三斜晶系,空间群为P_1~-,晶胞参数:a=1.0554(15) nm,b=1.201(17) nm,c=1.489(2) nm,α=93.24(2) °,β=102.14(2) °,γ=91.79(2) °,V=1.840(5) nm~3,F(000)=814,Z=1,Dc=1.408 g·cm~(-3),μ=0.648 mm~(-1),R_1=0.0973, wR_2=0.1929.配合物分子中每个Cu(II)离子以N4O1的五配位形式位于变形的三角双锥构型中.利用琼脂扩散法测试了该配合物的抑菌活性,结果表明对4种受试细菌均有一定的活性.     

一维镉(Ⅱ)配合物[Cd(H2ASA)2(H2O)2]n的合成、晶体结构及光致变色性质

以5-偶氮四唑水杨酸(H3ASA)和CdCl2·2.5H2O为原料,通过常规溶液法合成了一个镉配合物[Cd(H2ASA)2(H2O)2]n(1).通过X-射线单晶衍射、X-射线粉末衍射、元素分析、红外光谱、热重分析、紫外光谱进行结构解析和性质表征.结果 表明配合物1属于三斜晶系,Pi空间群,晶胞参数为a =0.702 39(5) nm,b=0.735 15(6) nm,c=1.229 41(7)nm,α =82.557(5)°,β=75.453(6)°,γ =61.882(8)°,V=0.541 90(8) nm3,Z=1,μ=1.083 mm-1,Dc=1.884g/cm3.配合物1中具有H2ASA-,作为μ2-桥联配体连接两个不同的Cd(Ⅱ)离子形成无限一维链结构,相邻直链通过O…O、O…N氢键和π-π堆积作用形成三维超分子框架.紫外光谱测试表明配合物1在365 nm紫外光照射下具有光致异构性质.     

亚苄基丙酮苯甲酰腙Co(Ⅱ)配合物的合成、晶体结构及抑菌活性

采用亚苄基丙酮苯甲酰腙配体(HL)与Co(NO3)2溶液进行反应,得到一个配合物Co(LPy)2,并对配合物进行X-射线单晶衍射、元素分析、红外光谱、热重分析表征.X-射线单晶衍射结果表明:该配合物为扭曲四角双锥构型,属三斜晶系,属于P1空间群,晶胞参数为a=1.0747(4) nm,b=1.3508(6) nm,c=1.4390(6) nm,α=83.661(8)°,β=84.561(8)°,γ=66.582(7)°,V=1.9022 (14) nm3,Z=2,F(000) =782,R1=0.0611.使用滤纸片琼脂扩散法测定了配体(HL)和配合物Co(LPy)2对大肠杆菌、金黄色葡萄球菌和绿脓杆菌的抑菌活性.抑菌实验结果表明,配体(HL)和配合物Co(LPy)2对三种细菌均有一定的抑制作用.     

一种双核铜配合物[Cu(II)2(Paba)2(4,4'-Bipy)(H2O)2]·(ClO4)2的合成、表征及晶体结构

在水和甲醇的溶剂中合成了标题配合物[Cu(II)2(Paba)2(4,4'-Bipy)(H2O)2]·(ClO4)2 [PabaH=2-(2-吡啶甲基亚氨基)苯磺酸],通过红外光谱、元素分析、X射线单晶衍射等手段对配合物进行了表征.结果表明,该配合物晶体属于单斜晶系,空间群为P2(1)/n. 晶体学参数: a=14.559(2) nm, b=0.95984(13) nm, c=1.6038(2) nm, α=γ=90°, β=115.694(2)°, V=2.0197(5) nm3, Z=2.     

乙二胺四乙酸铋(Ⅲ)双核配合物的合成和晶体结构

以乙二胺四乙酸(H4edta)的配合物[Sb(Hedta)]·H2O和硝酸铋为主要原料,在水溶液中合成了双核的二维网状配合物[Bi2 (Hedta)2]·4H2O,用元素分析、X射线单晶衍射法、红外光谱以及热分析等方法进行了组成和结构表征.结果表明该配合物属于单斜晶系,空间群Cc,晶胞参数为a=1.720419(15) nm,b=0.68549 (5) nm,c=1.32906(11) nm,β=105.7590 (10)°,V=1.5085 (2) nm3,Z=2,Dc=2.352 g·cm-3,μ=11.744 mm-1,F(000)=1016,R1=0.0556,wR2 =0.1393.在该配合物中,Bi (Ⅲ)与同一个Hedta3-配体中的4个羧基O原子和2个氨基N原子以及来自两个不同Hedta3-配体的桥联羧基氧原子结合,形成了配位数为8的双帽三棱柱构型.配合物的热分解过程包括失水、配体的氧化分解,最后在450℃失重恒定并形成Bi2O3.     

Synthesis and crystal structure of a terephthalato-bridged copper(II) complex [Cu2(tpt)(bpy)2(H2O)4] [Cu2(tpt)3 (bpy)2(H2O)2]

A terephthalato-bridged copper(II) complex [Cu₂(tpt)(bpy)₂(H₂O)₄][Cu₂(tpt)₃(bpy)₂ (H₂O)₂] (1) (tpt = terephthalate, bpy =; 2,2'-bipyridine) was synthesized by the reaction of Cu(ClO₄)₂ 6H₂O and terephthalic acid in the presence of 2,2'-bipyridine in H₂O solution. Crystal structure of 1 was determined by X-ray diffraction analysis in the triclinic space group P , with a = 10.7327(10) Å, b = 11.1658(11) Å, c = 17.3768(16) Å, = 108.063(2), = 91.064(2), = 116.721(2), V = 1737.5(3) ų, and Z = 2. Both the anion and the countercation in 1 are copper(II) complexes linked by terephthalate bridges in the bis(monodentate) (syn–anti) mode. The anion and the countercation are also linked by two hydrogen bonds between coordinating water molecules and terephthalate ligand.     

Synthesis and crystal structure of di(2-aminopyrimidinium) trichlorodimethyl(2-aminopyrimidine)stannate(IV) chloride (H-2APY)2[SnMe2Cl3(2APY)]Cl

The synthesis and molecular structure of di(2-aminopyrimidinium) trichlorodimethyl(2-aminopyrimidine)stannate(IV) chloride (H-2APY)₂[SnMe₂Cl₃(2APY)]Cl is reported. The compound crystallized in the orthorhombic space group Pnma with a = 20.524(1) Å, b = 10.822(1) Å, c = 10.472(1) Å and V = 2325.9(3) ų, Z = 4. The structure consists of three fragments: the hexacoordinated organotin anionic complex [SnMe₂Cl₃(2APY)]⁻, which exhibits distorted octahedral geometry; two protonated 2-aminopyrimidinium cations (H-2APY)⁺, and one chloride anion.

     

A Unique Example of a Co-crystal of [Co(AMTTO)2(H2O)2](NO3)2 and [Co(AMTTO)2(CH3CN)2](NO3)2 (AMTTO = 4-amino-5-methyl-1,2,4-triazol-3(2H)-thione)

A co-crystal of cobalt(II) complexes, Co(AMTTO)₂(CH₃CN)₂]²⁺(NO₃)₂. [Co(AMTTO)₂(H₂O)₂]²⁺(NO₃)₂, compound (1) was isolated from the reaction of Co(NO₃)₂?6H₂O and 4-amino-3-mercapto-6-methyl-5-oxo-1,2,4-triazine (AMTTO) in acetonitrile as solvent. Isolated crystals were characterized by elemental analyses, IR spectroscopy as well as X-ray diffraction studies. Crystal data for 1 at 95 K revealed a monoclinic space group P2₁/n, a?=?11.7903(5), b?=?12.1279(5), c?=?14.1443(6) Å, β?=?99.244(4)°, Z?=?2, R₁?=?0.0339. Compound 1 consists of two co-crystallized Co(II) complexes [Co(AMTTO)₂(CH₃CN)₂]²⁺ and [Co(AMTTO)₂(H₂O)₂]²⁺ and four nitrate counter anions In both complexes, cobalt(II) ions are in an octahedral arrangement. Two S, N bidentate AMTTO ligands are coordinated to both Co(II) ions. The coordination sphere of Co1 is completed by two acetonitrile molecules, and these positions are occupied by water molecules for Co2.

Graphic Abstract

A co-crystal of cobalt(II) compound was isolated from the reaction of Co(NO₃)₂?6H₂O and 4-amino-3-mercapto-6-methyl-5-oxo-1,2,4-triazine in acetonitrile as solvent.

     

Molecular structures of (tBu)Ga(S2CNnPr2)2 and (iPrO)Ga(S2CNEt2)2: An example of an unusual ligand pseudorotation

The molecular structures of (^tBu)Ga(S₂CNⁿPr₂)₂ (1) and (ⁱPrO)Ga(S₂CNEt₂)₂ (2) have been determined. The variation in the geometries observed for bis-dithiocarbamate compounds of gallium, (X)Ga(S₂CNMe₂)₂ (X=Cl, ⁱPrO, ^tBu) do not lie along the Berry pseudorotation pathway for the square-based pyramid to trigonal bipyramid geometrical transition. Instead, the structures appear to lie on an unusual ligand two-step, Texas, pseudorotation mechanism which results in a highly distorted trigonal bipyramidal geometry. Crystal data: (1) monoclinic, P2₁,/c, a = 9.786(1), b = 29.218(3), c = 9.452(1) Å, = 108.379(9)°, V = 2564.7(5) ų, and Z = 4. (2) Monoclinic, P2₁ /c, a = 10.980(3), b = 15.673(4), c = 12.461(3) Å, = 97.47(2)°, V = 2126.2(9) ų and Z = 4.     

Crystal structures of mixed compounds Cu(2)Gly(D-Ser)(L-Ser)2 and Cu(2)Gly 3(L-Ser)

-The crystal structures of mixed coordination compounds, Cu(2)Gly(D-Ser)(L-Ser)₂(I) and Cu(2)Gly ₃(L-Ser)(II), which contain the amino acid residues of glycine (Gly) and serine (Ser) in the 1: 3 and 3: 1 ratio, respectively, are studied by electron diffraction. Crystals I and II are triclinic, Z = 1, and space group P1. For I, a = 8.96(2) Å, b = 9.66(2) Å, c = 5.07(2) Å, α = β = 90°, and γ = 92.8(3)°. For II, a = 8.37(2) Å, b = 9.65(2) Å, c = 5.06(2) Å, α = β = 90°, and γ = 92.8(3)°. Compounds I and II have layered structures that are based on the CuGly(L-Ser) fragment. Structures I and II differ mainly in their interlayer spacing and configuration of the interlayer space.     

Crystal and molecular structures of 1-(2-carboxypropan-2-ylamino)-3-(1-naphthyloxy) propan-2-ol (1) (C17H21NO4) and 1-(2-carbamoyl propan-2-ylamino)-3-(1-naphthyloxy) propan-2-ol (2) (C17H22N2O3)

The crystal structures of two new-adrenergic antagonists, derivatives of propranolol containing 2-methylalanine fragment are described in this paper. The space groups and unit-cell parameters are: compound1 (C₁₇H₂₁NO₄): monoclinic, space groupP2₁/n,a=5.787(1),b=18.703(4),c=23.526(5)Å,=96.49(2)°; compound2 (C₁₇H₂₂N₂O₃): triclinic, space groupP¯1,a=8.321(1),b=10.121(1),c=10.368(1)Å,=109.49(1)°,=90.49(1)°, =103.48(1)°. The structures were solved by direct methods and refined with full matrix least-squares techniques toR indices of 0.055 and 0.049, respectively. The molecules of compound1 exist in the crystal as dual ions. The molecules of compound2 are compact and their external chain is twisted in a characteristic way (similar to that found in peptides).     

Crystal structure of [Mn2(III)(salpa)2Cl2(H2O)2] (H2salpa = 1-(salicylaldeneamino)-3-hydroxypropane)

The manganese complex, (Mn₂(III)(salpa)₂Cl₂(H₂O)₂], has been prepared and its structure determined using x-ray crystallography. The dimer is a di-₂-alkoxo complex which is a six-coordinate manganese dimer with unsupported alkoxide bridges and a rare example of a chloride- and water-containing manganese dimer. The complex crystallizes in the monoclinic space group P2₁/c with a = 9.315(5), b = 11.130(4), c = 11.637(5) Å, = 104.33(3)°, V = 1169.0(9) ų, and Z = 2. The structure comprises discrete binuclear clusters in which the metal atoms are bridged by two alkoxo oxygens of the salpa^2– ligands. The Mn—O and Mn—N distances are in good agreement with those found for other manganese(III) Schiff base complexes. The Mn—Cl and Mn—O3 distances are 2.585(2) and 2.371(2) Å, respectively, and the Mn ··· Mn distance is 3.001(1) Å. In the crystal, there are two types of hydrogen bonding between the H₂O molecule and the Cl atom with Cl ··· H(H₂O) distance of 2.33(6) (intramolecule: –1 + x, y, –1 + z) and 2.68(6) Å (intermolecule: –1 + x, 0.5–y, –0.5 + z).     

Crystal structure ofcis-diaqua bis(2,2′-bipyridyl)chromium(III) nitrate, [Cr(bipy)2(H2O)2] (NO3)3

cis-Diaquabis(2,2-bipyridyl)chromium(III) nitrate crystallizes in the mono-clinic system, space groupP2₁/c, witha=16.102(6),b=10.792(5),c=15.076(6) Å,=112.90(5)°, andZ=4. The saltlike structure was determined from X-ray crystallography and refined toR=7.5% for 3342 observed reflections. The Cr atom is octahedrally surrounded by twocis water molecules and by two chelated 2,2-bypiridyl ligands forming two nearly orthogonal planes. Selected bond distances are: Cr-O, 2.00(1) and 1.98(1) Å, Cr-N, 2.04 Å (mean).     

Crystal and molecular structures of 1-(2-methyloxycarbonylo-propan-2-ylamino)-3-(1-naphthyloxy) propan-2-ol hydrochloride (1) (C18H24NO4Cl) and 1-(2-methylcarbamoylpropan-2-ylamino)-3-(1-naphthyloxy) propan-2-ol (2) (C18H24N2O3)

The crystal structures of two new-adrenergic antagonists, derivatives of propranolol, are reported in this paper. The space groups and unit-cell parameters are: compound1 (C₁₈H₂₄NO₄Cl), monoclinic,P2₁,a=7.215(1),b=8.591(1),c=15.017(1)Å,=95.64(1)°; compound2 (C₁₈H₂₄N₂O₃), monoclinic,P2₁/c,a=10.218(3),b=21.616(5),c=8.124(2)Å,=101.28(2)°. The structures were solved with direct methods and refined by full-matrix least-squares techniques toR indices of 0.036 and 0.066, respectively. The molecule of compound1 has an extended external chain, and thus its structure is linear, whereas the molecule of compound2 is compact, and its external chain is twisted in a characteristic way, as is the case of peptides.